Notice: This company has been marked as potentially delisted and may not be actively trading. NASDAQ:GHSI Guardion Health Sciences (GHSI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisDividendEarningsHeadlinesInsider TradesShort InterestTrends About Guardion Health Sciences Stock (NASDAQ:GHSI) 30 days 90 days 365 days Advanced Chart Remove Ads Get GHSI alerts:Sign Up Key Stats Today's Range$3.22▼$3.2950-Day Range$3.22▼$3.5052-Week Range$3.04▼$18.00Volume4,700 shsAverage Volume105,261 shsMarket Capitalization$4.35 millionP/E Ratio0.66Dividend Yield155.28%Price TargetN/AConsensus RatingN/A Company OverviewGuardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.Read More… Remove Ads Receive GHSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GHSI Stock News HeadlinesGuardion Health Sciences Announces Declaration of Cash DistributionDecember 23, 2024 | globenewswire.comGuardion Health Sciences Announces Filing of Certificate of DissolutionOctober 30, 2024 | globenewswire.comLying in hospital… staring at the light"Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune. After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him.March 18, 2025 | Porter & Company (Ad)Guardion Health Sciences Announces Delisting and New Interim CEOOctober 5, 2024 | finance.yahoo.comGuardion Health Sciences Inc (GHSI)October 3, 2024 | investing.comGuardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, PresidentOctober 1, 2024 | marketwatch.comGuardion Health Sciences Announces Adoption of Plan of Dissolution and Liquidation; Appointment of Interim President and CEOOctober 1, 2024 | finance.yahoo.comWhy Guardion Health Sciences (GHSI) Stock Is Getting HammeredOctober 1, 2024 | msn.comSee More Headlines GHSI Stock Analysis - Frequently Asked Questions How were Guardion Health Sciences' earnings last quarter? Guardion Health Sciences, Inc. (NASDAQ:GHSI) announced its earnings results on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The business had revenue of $0.26 million for the quarter. Guardion Health Sciences had a net margin of 22.79% and a negative trailing twelve-month return on equity of 73.69%. When did Guardion Health Sciences' stock split? Guardion Health Sciences shares reverse split before market open on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did Guardion Health Sciences IPO? Guardion Health Sciences (GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital served as the underwriters for the IPO. What other stocks do shareholders of Guardion Health Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Acasti Pharma (ACST), iBio (IBIO) and General Electric (GE). Company Calendar Last Earnings8/12/2019Today3/18/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:GHSI CIK1642375 Webwww.guardionhealth.com Phone(800) 873-5141Fax858-630-5543Employees10Year Founded2009Profitability EPS (Most Recent Fiscal Year)$4.87 Trailing P/E Ratio0.66 Forward P/E RatioN/A P/E GrowthN/ANet Income$160,000.00 Net Margins22.79% Pretax Margin-20.29% Return on Equity-73.69% Return on Assets-48.17% Debt Debt-to-Equity RatioN/A Current Ratio16.68 Quick Ratio16.59 Sales & Book Value Annual Sales$12.25 million Price / Sales0.35 Cash Flow$0.14 per share Price / Cash Flow23.15 Book Value$6.39 per share Price / Book0.50Miscellaneous Outstanding Shares1,350,000Free Float1,332,000Market Cap$4.35 million OptionableNot Optionable Beta0.73 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:GHSI) was last updated on 3/18/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardion Health Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardion Health Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.